All stock lists
Avalyn Pharma Inc. (NASDAQ:AVLN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$30.59-$1.03 (-3.26%)
Market cap
$1.36B
Insider Score
Health Score
Analyst consensus
Listed since
Apr 30, 2026
Website
Insider Score
––Not scored
AVLN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AVLN analyst forecast
AVLN analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
AVLN 12-month price target
$55.50+81.4% upsideaverage of 2 firms
$60.00High
$51.00Low
Best analysts covering AVLN
No firm covering AVLN has a call old enough to have finished a 1Y holding period yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
AVLN analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Raymond James | — | $60.00 | +118.8% | Price target | 2026-10-02 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-08-13 |
| Evercore ISI | — | $51.00 | +79.5% | Price target | 2026-05-26 |
AVLN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-06-03 | -$5.98 | -$21.83 | $0 | $0 |
| 2026-08-12 | -$0.78 | -$0.98 | $0 | $0 |
| 2026-11-12 | -$0.70 | $0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.